Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 2/20 | 0.61 |
| ▸ | PDE1A | P54750 | 2/20 | 0.61 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.61 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PDE5A | O76074 | 2/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.41 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13368836 | 0.87 | PDE2A (0.47) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL4621727 | 0.85 | PDE2A (0.51) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL1460912 | 0.85 | PDE1A (0.58) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL1959299 | 0.85 | PDE1A (0.58) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL13368837 | 0.84 | PDE2A (0.45) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL19583186 | 0.83 | KDM4E (0.43) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL10963141 | 0.82 | ADORA2A (0.55) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL4796596 | 0.82 | PDE1A (0.46) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL272517 | 0.81 | KDM4E (0.41) | PDE2APDE1APDE1BPDE1CALDH1A1 | |
| SCHEMBL6234430 | 0.81 | PDE5A (0.64) | PDE2APDE1APDE1BPDE1CALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11714 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233983-A1 | DRUGS AND COMPOSITIONS FOR USE IN THE TREATMENT OF RETT SYNDROME | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2025-11-13 | — | — | WO | claimed |
| US-20250325591-A1 | THERAPY FOR HEPATIC DISORDERS USING ADIPOSE-DERIVED MESENCHYMAL STEM CELL LINE | UNIV KEIO (JP) | 2025-10-23 | — | — | US | claimed |
| US-20250283041-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | ALBERT EINSTEIN COLLEGE MEDICINE (US) | 2025-09-11 | — | — | US | claimed |
| EP-4146791-B1 | A MEDIUM-BASED METHOD REALIZED FOR DIFFERENTIATION OF DENTAL STEM CELLS INTO NEURONS | UNIV YEDITEPE (TR) | 2025-08-06 | — | — | EP | claimed |
| EP-4558616-A1 | METHODS FOR DIFFERENTIATING AT2 CELLS | Lung Biotechnology PBC (US) | 2025-05-28 | — | — | EP | claimed |
| EP-4558614-A1 | METHODS FOR DIFFERENTIATING EPITHELIAL OR BASAL CELLS | Lung Biotechnology PBC (US) | 2025-05-28 | — | — | EP | claimed |
| US-20250115872-A1 | GENERATION OF BROWN ADIPOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2025-04-10 | — | — | US | claimed |
| EP-4532693-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | Albert Einstein College of Medicine (US) | 2025-04-09 | — | — | EP | claimed |
| US-20250092368-A1 | METHOD OF MANUFACTURING ALVEOLAR ORGANOID USING ALVEOLAR CELL-DERIVED INDUCED PLURIPOTENT STEM CELLS | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2025-03-20 | — | — | US | claimed |
| WO-2025033531-A1 | TREATMENT OF TENDON DISORDERS USING PLATELETS PRODUCED FROM ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELL LINE | 慶應義塾 | 2025-02-13 | — | — | WO | claimed |
| US-5171217-A | Injecting drug carried on microparticles of biocompatible biodegradable polymer into vessel wall under directed pressure | INDIANA UNIVERSITY FOUNDATION (US) | 1992-12-15 | — | — | US | claimed |
| WO-1992021981-A1 | METHODS AND COMPOSITIONS FOR THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFLAMMATORY SEROSAL DISEASE AND RELATED CONDITIONS | BAXTER INTERNATIONAL INC. (US) | 1992-12-10 | — | — | WO | claimed |
| WO-1992015282-A2 | COMPOSITION AND METHOD FOR DELIVERY OF DRUGS | INDIANA UNIVERSITY FOUNDATION (US) | 1992-09-17 | — | — | WO | claimed |
| EP-0308460-B1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | Kabi Pharmacia AB (SE) | 1992-07-29 | — | — | EP | claimed |
| US-5079253-A | COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1992-01-07 | — | — | US | claimed |
| US-4902690-A | SYNERGISTIC COMBINATION OF PHOSPHODIESTERASE INHIBITOR AND OCTOPAMINE AGONIST | THE GENERAL HOSPITAL CORPORATION (US) | 1990-02-20 | — | — | US | claimed |
| EP-0308460-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION. | PHARMACIA AB (SE) | 1989-03-29 | — | — | EP | claimed |
| US-4800081-A | CALCIUM INFLUX BLOCKER SYNERGISTIC WITH INTERFERON OR CYCLIC NUCLEOTIDE MODULATOR | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-01-24 | — | — | US | claimed |
| WO-1988007380-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1988-10-06 | — | — | WO | claimed |
| WO-1987007508-A1 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-12-17 | — | — | WO | claimed |